Gowling WLG advised ITM on the Joint Venture. ITM Isotope Technologies Munich SE (“ITM”), a leading radiopharmaceutical biotech company, and Canadian Nuclear Laboratories (“CNL”), the manager...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Cybin on the acquisition. Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) (“Cybin”) has successfully acquired Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF) (“Small...
You must be a Standard 1 Year member to access this content.
Gowling WLG advised Providence Therapeutics Holdings Inc. on the deal. Everest Medicines Limited announced two separate definitive agreements with Providence Therapeutics Holdings Inc., a clinical stage...
You must be a Standard 1 Year member to access this content.
